Cefmetazole sodium

头孢美唑钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefmetazole sodium
Drug Alias Namecefmetazolum氰唑甲氧头孢菌素头孢子菌素Zefazone头孢类美唑钠 +[12
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsGonorrheaBacterial Infections
Global Approved IndicationsGonorrheaBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1989/12/11
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesPharmacia & Upjohn
Active IndicationsBacterial Infections
Inactive IndicationsGonorrhea

Other Information

ATC CodeJ01DC09